Health Care: Drugs

Dendreon Corp (DNDN: NASDAQ)

$1.42 -0.06 | -4.05%
09/18/14 - 04:14 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 283.75M 325.53M 341.61M 48.06M
Cost of Sales 104.39M 158.67M 96.87M 10.90M
Gross Operating Profit 179.36M 166.86M 244.75M 37.16M
Selling, General, and Administrative Expenses 232.85M 317.13M 361.34M 235.76M
Research & Development 70.83M 74.64M 74.29M 75.94M
Operating Income before D & A (EBITDA) -124.32M -224.92M -190.89M -274.54M
Depreciation & Amortization 61.94M 69.22M 62.22M 17.62M
Interest Income 667.00K 1.34M 1.42M 1.14M
Other Income - Net -85.00K 101.00K 180.00K -147.28M
Special Income / Charges -46.25M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -242.44M -338.36M -290.10M -438.30M
Interest Expense 54.36M 55.25M 47.70M 1.59M
Pre-Tax Income -296.80M -393.61M -337.81M -439.89M
Income Taxes 0.00 0.00 0.00 -411.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -296.80M -393.61M -337.81M -439.48M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -296.80M -393.61M -337.81M -439.48M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -296.80M -393.61M -337.81M -439.48M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-240.04M -347.94M -299.22M -439.48M
Preferred Dividends
Net Income Available To Common -296.80M -393.61M -337.81M -439.48M
Basic EPS from Continuing Ops. -1.95 -2.65 -2.31 -3.18
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.95 -2.65 -2.31 -3.18
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.95 -2.65 -2.31 -3.18
Basic Normalized Net Income/Share -1.58 -2.34 -2.05 -3.18
EPS fr Continuing Ops. -1.95 -2.65 -2.31 -3.18
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.95 -2.65 -2.31 -3.18
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.95 -2.65 -2.31 -3.18
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.58 -2.34 -2.05 -3.18
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with DNDN

Latest DNDN Headlines from TheStreet

More Financial News for DNDN

Press Releases for DNDN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter